Maintaining open communication between patients and healthcare providers ensures that any nutritional concerns are addressed promptly whilst maximising the benefits of weight management therapy
Hill NR, Fatoba ST, Oke JL, Hirst JA, OCallaghan CA, Lasserson DS, et al
A landmark trial published in the New England Journal of Medicine found that participants using semaglutide 2.4mg lost an average of 14.9% of their body weight over 68 weeks, significantly outperforming placebo across all measured outcomes (Wilding et al., NEJM, 2021, Pennsylvania residents across the state, from Center City Philadelphia to the rural communities of the north-central mountains, have real and practical access to semaglutide today
Epitalon will have to activate these mechanisms and several rounds of cellular division may be required before we see any increase in telomere length